Up-Regulation Of Mir-221 Mediates The Pioglitazone-Induced Inhibition Of Vascular Endothelial Cell Proliferation

Ben Huang,Wenshuo Wang,Ye Yang,Shuyang Lu,Jiayu Zheng,Lai Wei,Chunsheng Wang

2016-01-01

Abstract:Given that angiogenesis plays a vital role in development of cancer, a becoming anti-tumor strategy is anti-angiogenic. Although the anti-angiogenic effect of pioglitazone has been known already, the detailed molecular mechanism, which accounts for the endothelial cells (ECs) to proliferation inhibited by pioglitazone, is limited, particularly concerning their posttranscriptional regulation involving miRNA. In present study, we provide the mechanistic link between pioglitazone and its anti-angiogenic activity. Primarily, using immumofluorescence and CCK-8 assay, we find pioglitazone inhibits the ECs proliferation. During this inhibiting process, 12 microRNAs (miRNAs) show significant differences at relative gene abundance in which miR-221 presents a highest up-regulated expression. In following experiment, we demonstrate that expression of miR-221 mediated by pioglitazone positively correlate with anti-angiogenic action of pioglitazone. At last, we discover that pioglitazone augments the reduction of p27 mRNA level in ECs by up-regulating miR-221. Collectively, we have exploited a valuable mechanism by which up-regulation of miR-221 contributes to the pioglitazone-induced inhibition vascular EC proliferation, which raise a possibility that inhibition of miR-221 may be a potential strategy for therapeutic intervention in excessive vascular EC proliferation.